Gastric inhibitory polypeptide, also known as glucose-dependent insulinotropic polypeptide, is an inhibiting hormone of the secretin family of hormones. From Wikipedia
The first head-to-head study confirms tirzepatide's superior efficacy, while semaglutide retains unique cardiovascular benefits.
